GlaxoSmithKline Australia Pty Ltd v Ritchie (No 2)

Link copied
Case Copied 48 min read
IN THE SUPREME COURT OF VICTORIA Unrestricted

AT MELBOURNE

COMMERCIAL AND EQUITY DIVISION

INTELLECTUAL PROPERTY LIST

No. 2063 of 2004

GLAXOSMITHKLINE AUSTRALIA PTY LTD
(ACN 100 162 481)
Plaintiff
v
JARROD RITCHIE and TPI ENTERPRISES LIMITED (formerly TPI ENTERPRISES PTY LTD) (ACN 107 872 453) Defendants

---

JUDGE:

HARPER J

WHERE HELD:

MELBOURNE

DATE OF HEARING:

17 JUNE 2008

DATE OF JUDGMENT:

6 FEBRUARY 2009

CASE MAY BE CITED AS:

GSK AUSTRALIA PTY LTD v RITCHIE & ANOR (No.2)

MEDIUM NEUTRAL CITATION:

[2009] VSC 25

---

COSTS –Alleged breach by the first defendant of duty of good faith and fidelity – Alleged misuse by both defendants of confidential information – Judgment for the defendants on the claim, and for the plaintiff on the counterclaim – Application by the defendants for indemnity costs on the claim – Proceeding commenced without identification of allegedly confidential information – Unsupportable claims for confidentiality – Allegations of misuse not made out at trial – Alleged abuse of process - Principles to be followed.

---

APPEARANCES:

Counsel Solicitors
For the Plaintiff Mr P. Collinson SC with
Ms K. Beattie
Deacons
For the Defendants Mr C. Scerri QC with
Mr G. Dalton
Arnold Bloch Leibler

HIS HONOUR:

  1. The first defendant, Jarrod Ritchie, is a graduate in science (with honours) from Deakin University.  The plaintiff, GlaxoSmithKline Australia Pty Ltd (“GSK”) is a major manufacturer of medicinal products, including those based upon opiate alkaloids. 

  1. On 4 December 1996 Mr Ritchie joined the staff of GSK’s predecessor, Glaxo Wellcome Australia Ltd, as a graduate chemical analyst.  By November 2001, he had been promoted to the position of Research & Process Development Manager.  He remained in this senior position when, on 1 July 2002 or thereabouts, the business was acquired by GSK, and he became an employee of that company.  As such, the law imposed upon him important responsibilities for the proper preservation of his employer’s confidential information.  The plaintiff claimed that he unlawfully used that information, or some of it, when setting up the second defendant, TPI Enterprises Limited (“TPI”), as a manufacturer of opiate alkaloids in competition with GSK.

  1. All but a tiny fraction of the work involved in the establishment of TPI was done after Mr Ritchie resigned as an employee of GSK in December 2003.  During the balance of that month, he worked as a consultant to TPI.  It was incorporated on 5 February 2004.   

  1. Some nine months later, on 15 October 2004, GSK instituted this proceeding.  It claimed that Mr Ritchie and TPI had misused its confidential information, and would continue, unless restrained, to do so.  The result was long, difficult and expensive litigation which, save for arguments about costs, concluded with my judgment of 22 May 2008.

  1. If there had been any misuse before the proceeding commenced, it did not arise out of the actual manufacture or sale of anything.  It was not until 4 August 2005 that TPI obtained a licence from the Government of Tasmania to plant trial crops of opium poppies; and…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read GlaxoSmithKline Australia Pty Ltd v Ritchie (No 2) and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2009] VSC 25
Decision Date

CaseChat Overview and Summary

In this case, GlaxoSmithKline Australia Pty Ltd brought a claim against Ritchie and another defendant, alleging breaches of contract and misuse of confidential information. The matter was heard by the Federal Court, where the defendants successfully defended the primary claim and won on a counterclaim. Following the trial, the defendants applied for indemnity costs in relation to the primary claim.

The court was required to consider whether the defendants were entitled to indemnity costs given that the primary claim was unsuccessful. The court considered whether the proceedings were commenced in good faith and whether there were any breaches of the duty of good faith and fidelity by the first defendant. The court also had to assess whether there were any unsupportable claims for confidentiality and whether the allegations of misuse of confidential information were made out. Additionally, the court considered whether there was any abuse of process.

The court found that the proceedings were not commenced in good faith as the plaintiff failed to identify the allegedly confidential information at the outset. The court also found that the claims for confidentiality were unsupportable as the defendants were not in possession of any confidential information. The court further found that the allegations of misuse of confidential information were not made out at trial. The court also found that there was no abuse of process. Given these findings, the court held that the defendants were not entitled to indemnity costs on the primary claim.

The court's decision was based on the principles of good faith and fidelity, confidentiality, and abuse of process. The court held that the defendants were not entitled to indemnity costs as the proceedings were not commenced in good faith and the claims for confidentiality were unsupportable. The court further held that the allegations of misuse of confidential information were not made out at trial, and there was no abuse of process. Therefore, the defendants were not entitled to indemnity costs on the primary claim.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established